Grifols

Grifols Receivables

The Accounts Receivable of Grifols (GRF.MC) as of Nov 2, 2026 is 741.43 M EUR. In the previous year, Accounts Receivable was 692.86 M EUR — a change of 7.01% (higher).

Receivables

741.43 MEUR

YoY

7.01%

Last updated:

Accounts Receivable of Grifols is 2024 741.43 M EUR. Accounts Receivable of Grifols was 2023 692.86 M EUR. It decreases by 7.01% higher compared to the previous year.

The Grifols Receivables history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Receivables
Date
Receivables
Jan 1, 2017
286.20 M EUR
Jan 1, 2018
269.17 M EUR
Jan 1, 2019
369.80 M EUR
Jan 1, 2020
383.23 M EUR
Jan 1, 2021
434.14 M EUR
Jan 1, 2022
643.84 M EUR
Jan 1, 2023
692.86 M EUR
Jan 1, 2024
741.43 M EUR
The Grifols Receivables history
YEARReceivablesYoY
741.43 MEUR+7.01%
692.86 MEUR+7.61%
643.84 MEUR+48.30%
434.14 MEUR+13.28%
383.23 MEUR+3.63%
369.80 MEUR+37.39%
269.17 MEUR-5.95%
286.20 MEUR-30.81%
413.66 MEUR+14.14%
362.41 MEUR-27.63%
500.75 MEUR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Grifols Stock analysis

What does Grifols do? Grifols SA is a globally operating company specialized in the manufacture and marketing of medical products and technologies. The company is headquartered in Barcelona, Spain and has been in existence for over 75 years. Grifols focuses on improving the quality of life through the production and marketing of blood products and services, diagnostics, and hospital pharmaceuticals. It has four main business areas: Bioscience, Hospital, Diagnostic, and Bio Supplies. Grifols emphasizes research and development to meet customer needs. It has introduced various products, including AlfaBIO, Vistogard, ID Core XT, NEO Blood Bank, and MIRASOL Pathogen Reduction Technology. Grifols is committed to innovation and quality, providing products and services that cater to a wide range of customers. Additionally, it is a significant employer in the biotechnology industry and contributes to economic development in different regions. Grifols is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Grifols stock

Accounts Receivable of Grifols is 741.43 M EUR in 2024.

Accounts Receivable of Grifols changed from 692.86 M EUR to 741.43 M EUR, representing a 7.01% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Accounts Receivable Grifols since 2006 – with annual values, charts, and detailed analysis.

Receivables represent money owed to the company by customers for goods or services delivered. High receivables relative to revenue may indicate collection issues.

Accounts Receivable's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Accounts Receivable's Grifols historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Grifols

All Key Metrics — Grifols